Vitality Watch

Dossier pubmed preclinical 01-nov-2026
Animal model, organoid, or cell-culture result — not yet human

Tree Shrew as an Emerging Model for Aging Research: Characterization of Senescence and Therapeutic Interventions.

Key claim: Tree shrews recapitulate human transcriptional aging trajectories and pathologies significantly better than mice, and show human-concordant rejuvenation responses to dasatinib and quercetin senolytic treatment.

Abstract

Aging is characterized by progressive physiological decline and increased susceptibility to age-related diseases. Conventional rodent models have contributed significantly to our understanding of aging, yet their translational relevance is limited by substantial evolutionary divergence from humans. Here, we introduce the tree shrew (Tupaia belangeri chinensis) as a novel and biologically relevant model organism for aging research. In vitro, we induced cellular senescence in tree shrew fibroblasts through ionizing radiation, doxorubicin treatment, or replicative exhaustion, all of which consistently triggered robust senescent phenotypes and a pronounced senescence-associated secretory phenotype (SASP), accompanied by upregulation of conserved senescence biomarkers. In vivo, aged tree shrews exhibited progressive physical frailty, metabolic dysfunction, organ fibroplasia, and spontaneous tumorigenesis. Transcriptomic profiling uncovered widespread age-related alterations across multiple tissues, prominently affecting pathways involved in chronic inflammation, extracellular matrix remodeling, and metabolic dysregulation. Further comparative transcriptomic analyses of liver and spleen tissues confirmed that tree shrews recapitulate conserved human aging transcriptional trajectories and core gene expression patterns, whereas mice displayed markedly divergent aging signatures. Notably, senolytic intervention with dasatinib and quercetin (D + Q) effectively reversed key transcriptional changes and ameliorated selected age-related pathologies, including hepatic steatosis. Importantly, the D + Q-induced transcriptomic responses in tree shrews exhibited markedly greater concordance with human aging signatures than did corresponding mouse datasets. Collectively, these findings establish the tree shrew as a translationally relevant aging model that bridges the gap between fundamental discovery and clinical application.

Why this matters

This animal-model study shifts attention from whether senolytics affect aging phenotypes to how faithfully the experimental species captures human aging and treatment responses. Reported human concordance in tree shrews offers a translational benchmark, but does not establish that dasatinib+quercetin produces clinical rejuvenation in humans or that tree shrews reliably predict human outcomes.

Source

Link

Briefing card

Tree Shrew as an Emerging Model for Aging Research: Characterization of Senescence and Therapeutic Interventions.
Stage: preclinical · pubmed · 01-nov-2026

If you take dasatinib plus quercetin for longevity, this tree shrew study does not establish that it extends human life.

Tree shrews recapitulate human transcriptional aging trajectories and pathologies significantly better than mice, and show human-concordant rejuvenation responses to dasatinib and quercetin senolytic treatment.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1111/acel.70781

build build 880 · 2bcef25 · 2026-11-18